BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18950553)

  • 1. Potential risks of calcium channel blockers in chronic kidney disease.
    Griffin KA; Bidani AK
    Curr Cardiol Rep; 2008 Nov; 10(6):448-55. PubMed ID: 18950553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective strategies.
    Raikou VD
    World J Nephrol; 2024 Mar; 13(1):89637. PubMed ID: 38596266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium channel blockers on renal function.
    Chan L; Schrier RW
    Annu Rev Med; 1990; 41():289-302. PubMed ID: 2184731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of amlodipine.
    Saruta T; Kanno Y; Hayashi K; Suzuki H
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S11-6. PubMed ID: 7783108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do calcium channel blockers have renal protective effects?
    Reams GP
    Drugs Aging; 1994 Oct; 5(4):263-87. PubMed ID: 7827397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease.
    Haider DG; Sauter T; Lindner G; Masghati S; Peric S; Friedl A; Wolzt M; Hörl WH; Soleiman A; Exadaktylos A; Fuhrmann V
    Kidney Blood Press Res; 2015; 40(6):630-7. PubMed ID: 26672999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors and the kidney. A risk-benefit assessment.
    Navis G; Faber HJ; de Zeeuw D; de Jong PE
    Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of amlodipine in hypertensive patients with renal dysfunction.
    Saruta T; Ishii M; Abe K; Iimura I
    Clin Cardiol; 1994 Jun; 17(6):317-24. PubMed ID: 8070149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazide Diuretics in Chronic Kidney Disease.
    Sinha AD; Agarwal R
    Curr Hypertens Rep; 2015 Mar; 17(3):13. PubMed ID: 25749608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers and renal function.
    Wilkinson R
    Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
    Toto RD; Tian M; Fakouhi K; Champion A; Bacher P
    J Clin Hypertens (Greenwich); 2008 Oct; 10(10):761-9. PubMed ID: 19090877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?
    Kloke HJ; Branten AJ; Huysmans FT; Wetzels JF
    Kidney Int; 1998 Jun; 53(6):1559-73. PubMed ID: 9607186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of diltiazem in primary hypertension.
    Sunderrajan S; Reams G; Bauer JH
    Hypertension; 1986 Mar; 8(3):238-42. PubMed ID: 3949375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of telmisartan in patients with advanced chronic kidney disease.
    Tokunaga M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Nakamata J; Fujimoto Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y; Tamura M
    Clin Nephrol; 2010 Feb; 73(2):139-46. PubMed ID: 20129021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal actions of calcium channel antagonists.
    Osswald H; Weinheimer G; Kapp JF
    J Neural Transm Suppl; 1990; 31():39-53. PubMed ID: 2074437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on renal function.
    Dupont AG
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
    PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.